CanadaBis Capital (TSXV:CANB) FCF Margin %: 13.37% (As of Oct. 2025)


What is CanadaBis Capital FCF Margin %?

CanadaBis Capital TSXV:CANB FCF Margin % is 13.37% as of Oct. 2025. The stock has 6 warning signs investors should review. Among 958 Drug Manufacturers companies, CanadaBis Capital ranks worse than 78.08% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. CanadaBis Capital's Free Cash Flow for the three months ended in Oct. 2025 was C$0.44 Mil. CanadaBis Capital's Revenue for the three months ended in Oct. 2025 was C$3.26 Mil. Therefore, CanadaBis Capital's FCF Margin % for the quarter that ended in Oct. 2025 was 13.37%.

As of today, CanadaBis Capital's current FCF Yield % is -101.70%.

The historical rank and industry rank for CanadaBis Capital's FCF Margin % or its related term are showing as below:

TSXV:CANB' s FCF Margin % Range Over the Past 10 Years
Min: -193.84   Med: -11.62   Max: 20.55
Current: -14.27

During the past 10 years, the highest FCF Margin % of CanadaBis Capital was 20.55%. The lowest was -193.84%. And the median was -11.62%.

TSXV:CANB's FCF Margin % is ranked worse than
78.08% of 958 companies
in the Drug Manufacturers industry
Industry Median: 2.445 vs TSXV:CANB: -14.27

CanadaBis Capital FCF Margin % Related Terms

CanadaBis Capital FCF Margin % Historical Data

* Premium members only.

The historical data trend for CanadaBis Capital's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CanadaBis Capital FCF Margin % Chart

CanadaBis Capital Annual Data
Trend Nov16 Dec17 Dec18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -28.53 -2.51 20.55 -3.31 -19.92

CanadaBis Capital Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -15.33 16.20 -113.87 8.28 13.37

TSXV:CANB vs ZTS: FCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, CanadaBis Capital's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CanadaBis Capital FCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CanadaBis Capital's FCF Margin % distribution charts can be found below:

* The bar in red indicates where CanadaBis Capital's FCF Margin % falls into.


CanadaBis Capital FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

CanadaBis Capital's FCF Margin for the fiscal year that ended in Jul. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Jul. 2025 )/Revenue (A: Jul. 2025 )
=-3.366/16.901
=-19.92 %

CanadaBis Capital's FCF Margin for the quarter that ended in Oct. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Oct. 2025 )/Revenue (Q: Oct. 2025 )
=0.436/3.261
=13.37 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 13.37% mean?
CanadaBis Capital (TSXV:CANB) has a FCF Margin % of 13.37% as of Oct. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on CanadaBis Capital and its competitors. According to the industry distribution chart, CanadaBis Capital ranks #748 out of 958 companies in the Drug Manufacturers industry, placing it in the top 78.1%.
Is CanadaBis Capital's FCF Margin % too high?
CanadaBis Capital's current FCF Margin % is 13.37%. The Drug Manufacturers industry median FCF Margin % is 2.45. CanadaBis Capital's value of 13.37% is 446.8% above this industry median. Based on the distribution chart, CanadaBis Capital ranks #748 out of 958 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does CanadaBis Capital's FCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, CanadaBis Capital ranks #748 out of 958 companies for FCF Margin %. This places CanadaBis Capital in the lower half of its industry. The industry median FCF Margin % is 2.45. CanadaBis Capital's value of 13.37% is 446.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.45, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CanadaBis Capital's current FCF Margin % of 13.37% is 446.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on CanadaBis Capital and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CanadaBis Capital's current FCF Margin % is 13.37%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CanadaBis Capital stock overvalued right now?
CanadaBis Capital (TSXV:CANB) has a current FCF Margin % of 13.37%. The stock's GF Value™ is C$0.07, compared to a current price of C$0.02 — trading 78.6% below its estimated fair value. The current FCF Margin % is 13.37% and 446.8% above the Drug Manufacturers industry median of 2.45. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For CanadaBis Capital (TSXV:CANB), the current FCF Margin % is 13.37% as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CanadaBis Capital Business Description

Other Exchanges CNADF:USA
Address 255C Clearview Drive, Red Deer County, Red Deer, AB, CAN, T4E 3B6
CanadaBis Capital Inc is a vertically integrated cannabis company. The firm engages in the production and sale of recreational cannabis. Its product line consists of Stigma Roots. It operates in three segments: wholesale, retail, and extract. The wholesale segment cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards. Retail segment involves sale of cannabis and cannabis-related products to end consumers on-premises owned and operated by the Company. Extract segment provides cannabinoid extraction services to other licensed producers. The company generates maximum of its revenue from Extract Segment.